Luisa Lina Villa

Citované v

	Všetky	Od 2020
Citácie	39986	8722
h-index	92	44
i10-index	363	235

2400

1200

600

1800

19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025140 93 134 162 199 316 338 429 627 1021 1645 1899 2005 2006 2153 2262 2398 2287 2139 2113 1944 1882 1820 1903 1847 1631 1563 1536 235

Verejný prístup

všetky položky

140 článkov

2 články

dostupné

nedostupné

Na základe mandátov na financovanie

Spoluautori

Dr. Jorge SalmerónCentro de Investigación en Políticas, Población y Salud. Facultad de Medicina, UNAMOverená e-mailová adresa na: unam.mx
Enrique BoccardoProfessor of Virology, Institute of Biomedical Sciences, University of São PauloOverená e-mailová adresa na: usp.br
Lara TerminiScientific Researcher - ICESP - Faculdade de Medicina da USPOverená e-mailová adresa na: hc.fm.usp.br
Ana Paula LepiqueUniversidade de São PauloOverená e-mailová adresa na: icb.usp.br
Trottier HelenUniversité de Montréal / Sainte-Justine HospitalOverená e-mailová adresa na: umontreal.ca
Luiz Carlos ZeferinoProf Titular em Ginecologia, Fac Ciências Médicas. Diretor da Divisão de Oncologia do CAISM, UNICAMPOverená e-mailová adresa na: fcm.unicamp.br
José Humberto Tavares Guerreiro Fre...A. C. Camargo Cancer CenterOverená e-mailová adresa na: accamargo.org.br
Silvia Helena Rabelo-SantosProfessora de Citologia Clínica, Faculdade de Farmácia, Universidade Federal de GoiásOverená e-mailová adresa na: ufg.br
Christine M. PierceMerck & Co., Inc.Overená e-mailová adresa na: merck.com
Sophie DerchainProfessor of Gynecology, State University of CampinasOverená e-mailová adresa na: pq.cnpq.br
Itzel E Calleja-MaciasVanguard UniversityOverená e-mailová adresa na: vanguard.edu
Mark SchiffmanNational Cancer InstituteOverená e-mailová adresa na: mail.nih.gov
Tatiana RabachiniUniversity of Bern - SwitzerlandOverená e-mailová adresa na: pki.unibe.ch
Salaheddin MahmudProfessor and Canada Research Chair of Pharmaco-epidemiology, University of ManitobaOverená e-mailová adresa na: mcgill.ca
Matthew B. Schabath, Ph.D.H. Lee Moffitt Cancer Center & Research InstituteOverená e-mailová adresa na: moffitt.org
Silvya Stuchi Maria-EnglerFull Professor of School of Pharmaceutical Sciences, University of São PauloOverená e-mailová adresa na: usp.br
John T. SchillerNational Caner Institute, NIHOverená e-mailová adresa na: mail.nih.gov
Luciana Yuki TomitaFederal University of Sao PauloOverená e-mailová adresa na: unifesp.br
Marly Augusto CardosoDepartamento de Nutrição, Faculdade de Saúde Pública, Universidade de São PauloOverená e-mailová adresa na: usp.br
Suely NonogakiPesquisador científico do Instituto Adolfo LutzOverená e-mailová adresa na: ial.sp.gov.br

Sledovať

Luisa Lina Villa

Professora de Oncologia Básica, Depto Radiologia da Faculdade de Medicina da Universidade de São

Overená e-mailová adresa na: hc.fm.usp.br

câncer epidemiologia biologia molecular papilomavírus humano


Názov Zoradiť podľa citácií Zoradiť podľa roka Zoradiť podľa názvu	Citované v Citované v	Rok
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions Future II Study Group New England Journal of Medicine 356 (19), 1915-1927, 2007	2403	2007
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre … LL Villa, RLR Costa, CA Petta, RP Andrade, KA Ault, AR Giuliano, ... The lancet oncology 6 (5), 271-278, 2005	2378	2005
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer EL Franco, LL Villa, JP Sobrinho, JM Prado, MC Rousseau, M Désy, ... The Journal of infectious diseases 180 (5), 1415-1423, 1999	995	1999
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia NF Schlecht, S Kulaga, J Robitaille, S Ferreira, M Santos, RA Miyamura, ... Jama 286 (24), 3106-3114, 2001	884	2001
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a … KA Ault The Lancet 369 (9576), 1861-1868, 2007	873	2007
HPV type-distribution in women with and without cervical neoplastic diseases G Clifford, S Franceschi, M Diaz, N Muñoz, LL Villa Vaccine 24, S26-S34, 2006	827	2006
Updating the natural history of HPV and anogenital cancer AB Moscicki, M Schiffman, S Kjaer, LL Villa Vaccine 24, S42-S51, 2006	787	2006
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up LL Villa, RLR Costa, CA Petta, RP Andrade, J Paavonen, OE Iversen, ... British Journal of Cancer 95 (11), 1459-1466, 2006	744	2006
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in … DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... The Journal of infectious diseases 199 (7), 926-935, 2009	704	2009
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 LL Villa, KA Ault, AR Giuliano, RLR Costa, CA Petta, RP Andrade, ... Vaccine 24 (27-28), 5571-5583, 2006	693	2006
Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013	653	2013
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide … HU Bernard, SY Chan, MM Manos, CK Ong, LL Villa, H Delius, CL Peyton, ... Journal of Infectious Diseases 170 (5), 1077-1085, 1994	640	1994
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study AR Giuliano, JH Lee, W Fulp, LL Villa, E Lazcano, MR Papenfuss, ... The Lancet 377 (9769), 932-940, 2011	616	2011
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts … Future I/II Study Group The BMJ 341, c3493, 2010	552	2010
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women N Muñoz, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... Journal of the National Cancer Institute 102 (5), 325-339, 2010	490	2010
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia NF Schlecht, RW Platt, E Duarte-Franco, MC Costa, JP Sobrinho, ... Journal of the National Cancer Institute 95 (17), 1336-1343, 2003	460	2003
Human papillomavirus infections with multiple types and risk of cervical neoplasia H Trottier, S Mahmud, MC Costa, JP Sobrinho, E Duarte-Franco, ... Cancer Epidemiology Biomarkers & Prevention 15 (7), 1274-1280, 2006	459	2006
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States AR Giuliano, E Lazcano-Ponce, LL Villa, R Flores, J Salmeron, JH Lee, ... Cancer Epidemiology Biomarkers & Prevention 17 (8), 2036-2043, 2008	451	2008
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results JT Schiller, X Castellsagué, LL Villa, A Hildesheim Vaccine 26, K53-K61, 2008	423	2008
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, CM Wheeler, ... Cancer prevention research 2 (10), 868-878, 2009	419	2009

Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.

Články 1–20

Citácie za rok

Duplicitné citácie

Zlúčené citácie

Pridať spoluautorovSpoluautori

Sledovať

Citované v

Spoluautori